Genetics researchers at the UNC School of Medicine now have shown definitively that a small number of places in the human genome are associated with a large number and variety of diseases.
A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.
New research from UNC has established a new link between two fundamental epigenetic tags -- histone H3 lysine 9 methylation and DNA methylation -- in humans.
Study opens doors to better, more targeted therapies
A team from UNC Lineberger Comprehensive Cancer Center, shows in the laboratory that B cells from patients with chronic GVHD are much more active than cells from patients without the disease.
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.
A Randolph County woman with leukemia receives stem cells from her youngest brother in hopes of restoring her health and returning to work as a baker.
Julia Whitley, a rising 2nd year medical student in the UNC School of Medicine, received an American Society of Hematology (ASH) Trainee Research Award.
A UNC-led team of scientists describes the function of a previously uncharacterized protein that dramatically influences inflammation.
Carmina G. Valle, MPH, is the recipient of the competitive $5,000 award, which recognizes excellence in dissertation research focused on cancer and the population sciences.
A Bessemer City, N.C. woman is referred to UNC Hospitals for treatment of a recurrence of breast cancer and brings with her a posse of support and encouragement for the journey.
Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.
One of the reasons that cancer cells proliferate is that they metabolize fuel differently from normal cells. A team led by Blossom Damania, PhD, reports that two inter-related metabolic processes contribute to cell proliferation in non-Hodgkin lymphoma. Dr. Damania is professor of microbiology and immunology in the University of North Carolina School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center.
Parking difficulties inspired Barbara Riff to take motorcycle lessons with her son. Now she commutes to work via motorcycle and frequently takes motorcycle trips for fun.
Presents invited lecture at Harvard Medical School
Carey Anders, MD, and William Kim, MD, were awarded grants from the Damon Runyon Cancer Research Foundation.
Clinical trial shows response in fewer than 20 percent of patients.
Victoria Bae-Jump, MD, PhD, has received a two-year $200,000 grant from the Department of Defense, to study “Preclinical and Clinical Investigations of the Impact of Obesity on Ovarian Cancer Pathogenesis.”
Deborah Mayer, PhD, RN, AOCN, associate professor in the UNC School of Nursing, has been appointed to a three-year term on the Cancer Survivorship Committee of the American Society of Clinical Oncology.
A team of UNC researchers led by Norman Sharpless, MD, have identified a key genetic switch that determines whether melanoma, a lethal skin cancer, spreads by metastasis.